4.7 Article

Co-Delivery of p53 Restored and E7 Targeted Nucleic Acids by Poly (Beta-Amino Ester) Complex Nanoparticles for the Treatment of HPV Related Cervical Lesions

Related references

Note: Only part of the references are listed.
Review Pharmacology & Pharmacy

Rational designs of in vivo CRISPR-Cas delivery systems

Cong-Fei Xu et al.

Summary: The CRISPR-Cas system has revolutionized genome editing, but efficient delivery to target tissues/cells remains a challenge. This review summarizes the characteristics of different CRISPR-Cas therapeutic tools and investigates current in vivo delivery systems, emphasizing the requirements for efficient delivery in clinical settings and the safety of different tools.

ADVANCED DRUG DELIVERY REVIEWS (2021)

Review Pharmacology & Pharmacy

Delivery of CRISPR/Cas systems for cancer gene therapy and immunotherapy

Xiangrong Song et al.

Summary: CRISPR/Cas systems are efficient and versatile gene editing tools with enormous potential for cancer treatment. While preclinical studies using CRISPR/Cas systems for cancer treatment are underway, efficient and safe in vivo delivery remains a critical challenge for their clinical applications.

ADVANCED DRUG DELIVERY REVIEWS (2021)

Review Pharmacology & Pharmacy

Non-viral strategies for delivering genome editing enzymes

Jie Li et al.

Summary: Genome-editing tools like CRISPR have revolutionized various fields, but the low delivery efficiency of genome editing proteins in vivo remains a major challenge, with the most successful strategy currently involving potentially immunogenic viral vectors.

ADVANCED DRUG DELIVERY REVIEWS (2021)

Review Biotechnology & Applied Microbiology

CRISPR-Cas9: A Preclinical and Clinical Perspective for the Treatment of Human Diseases

Garima Sharma et al.

Summary: The revolutionary CRISPR-Cas9 technology has therapeutic potential against genetic disorders and is being tested in clinical trials for cancer treatment. In addition to therapeutic applications, it can also be used to create genetic animal models for drug discovery. However, challenges and safety concerns still need to be addressed in CRISPR-Cas9-mediated therapeutic approaches.

MOLECULAR THERAPY (2021)

Review Biotechnology & Applied Microbiology

Progress of cationic gene delivery reagents for non-viral vector

Kai Ma et al.

Summary: Gene delivery systems are crucial for gene therapy and recombinant protein production, with non-viral vector gene delivery reagents offering advantages such as large packaging load capacity and low immunogenicity. Liposomes and non-liposome cationic polymers are commonly used as gene delivery reagents, with different head structures including quaternary ammonium salt, amine, amino acid, polypeptide, guanidine salt, and a heterocyclic ring.

APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2021)

Article Oncology

A novel cancer preventative botanical mixture, TriCurin, inhibits viral transcripts and the growth of W12 cervical cells harbouring extrachromosomal or integrated HPV16 DNA

Linda Saxe Einbond et al.

Summary: TriCurin and its individual compounds demonstrate inhibitory effects on the growth of HPV (+) cells through inducing apoptosis and gene suppression. TriCurin in a microemulsion is stable and non-toxic to cervical tissue.

BRITISH JOURNAL OF CANCER (2021)

Article Oncology

Targeting the p53-MDM2 pathway for neuroblastoma therapy: Rays of hope

Atif Zafar et al.

Summary: Neuroblastoma poses a significant challenge in pediatric oncology, with p53 protein playing a key protective role against genome instability. Overexpression of MDM2 in neuroblastoma can lead to p53 inhibition, drug resistance, and other non-canonical p53 functions. Research is focused on restoring p53 function by targeting the p53-MDM2 axis for potential therapeutic strategies.

CANCER LETTERS (2021)

Review Oncology

Therapeutic potential of p53 reactivation in cervical cancer

Xiangxuan Zhao et al.

Summary: Cervical cancer is a common malignancy affecting women worldwide, with surgical resection being the most effective treatment at early stages. Dysregulation of the tumor suppressor p53 is associated with therapeutic insensitivity and relapse in CC, while restoration of p53 activity can inhibit tumor growth and eliminate drug resistance.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2021)

Article Biophysics

Augment the efficacy of eradicating metastatic lesions and tumor proliferation in breast cancer by honokiol-loaded pH-sensitive targeted lipid nanoparticles

Hongyan Zhang et al.

Summary: A valid strategy for delivering natural drug Hol has been proposed, using a non-toxic degradable pH-sensitive polymer and Folate-DSPE-PEG2000 outer layer to efficiently inhibit the migration and invasion of breast cancer cells while targeting tumor sites. This drug delivery system demonstrated marked anti-tumor and lung metastasis suppression effects in mice models, with elevated apoptosis levels and repression of metalloproteinase expression.

COLLOIDS AND SURFACES B-BIOINTERFACES (2021)

Article Medicine, General & Internal

Small-cell lung cancer

Charles M. Rudin et al.

Summary: Small-cell lung cancer is a type of lung cancer characterized by high proliferative rate, early metastasis, and poor prognosis, strongly associated with tobacco carcinogens. Most patients are diagnosed with metastatic disease, with only a small fraction having potentially curative earlier-stage disease. Genomic profiling reveals extensive chromosomal rearrangements and high mutation burden in SCLC, often involving inactivation of TP53 and RB1 tumor suppressor genes.

NATURE REVIEWS DISEASE PRIMERS (2021)

Review Oncology

Targeting mutant p53 for cancer therapy: direct and indirect strategies

Jiahao Hu et al.

Summary: TP53 is a critical tumor-suppressor gene commonly mutated in human cancers, with potential oncogenic properties when mutated. Treatments for cancers with mutant p53 involve targeting mutant p53 directly, restoring wild-type functions, and exploring synthetic lethal interactions with mutant p53 for therapeutic benefits. Additionally, disrupting noncoding RNA networks may have potential synthetic lethal effects in cancers with p53 mutations.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)

Review Chemistry, Multidisciplinary

Virus against virus: strategies for using adenovirus vectors in the treatment of HPV-induced cervical cancer

Momeneh Ghanaat et al.

Summary: Persistent infection with high-risk types of HPV is known to be the leading cause of cervical cancer, leading to the development of various therapeutic approaches, with adenovirus vectors drawing attention due to their strong immunogenicity and safety.

ACTA PHARMACOLOGICA SINICA (2021)

Article Peripheral Vascular Disease

Hydrogel-mediated delivery of microRNA-92a inhibitor polyplex nanoparticles induces localized angiogenesis

Fatemeh Radmanesh et al.

Summary: Localized delivery of miR-92a inhibitor using PEI-DA conjugates efficiently improves angiogenesis, as shown by enhanced expression of ITGA5, SIRT1, and KLF2/4, as well as increased capillary density in vitro and in vivo without cytotoxicity. This approach appears to be a safe and effective strategy for therapeutic targets in different disease models.

ANGIOGENESIS (2021)

Article Biochemistry & Molecular Biology

UVB Inhibits Proliferation, Cell Cycle and Induces Apoptosis via p53, E2F1 and Microtubules System in Cervical Cancer Cell Lines

Angelica Judith Granados-Lopez et al.

Summary: This study reveals the effects of UVB on cervical cancer cell lines, showing inhibition of cell proliferation, cell cycle arrest, and apoptosis induction. The response to UVB varied in different cell lines, with the severity depending on tumorigenesis level or HPV type. Analysis of UV-responsive proteins in SiHa cells indicated alterations in E2F1, p53, and microtubules system proteins in response to UVB exposure.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Chemistry, Multidisciplinary

Liposomes with Water as a pH-Responsive Functionality for Targeting of Acidic Tumor and Infection Sites

Da-Yuan Wang et al.

Summary: DCPA-H2O liposomes with high protonation capability demonstrated enhanced targeting to solid tumors and intra-abdominal infectious biofilms in murine models. Additionally, therapeutic efficacy of ciprofloxacin-loaded DCPA-H2O liposomes in infected wound-healing model exceeded that of clinically applied ciprofloxacin and other liposomes loaded with ciprofloxacin.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2021)

Article Engineering, Biomedical

Systemic delivery of mRNA and DNA to the lung using polymer-lipid nanoparticles*

James C. Kaczmarek et al.

Summary: Non-viral vectors can deliver nucleic acids into cells in vivo, with study showing that PBAEs with altered monomer chemistry can effectively deliver DNA or mRNA to lung endothelium in mice. Physical properties like particle size or charge do not explain differences in transfection efficacy, indicating tailored delivery vectors are needed for different nucleic acids. In vivo luciferase expression was significantly higher with mRNA compared to pDNA, highlighting the potential of PBAEs as intracellular delivery materials.

BIOMATERIALS (2021)

Review Cell Biology

Role of Dietary Antioxidants in p53-Mediated Cancer Chemoprevention and Tumor Suppression

J. P. Jose Merlin et al.

Summary: Cancer prevention and treatment involve multiple factors, including genetics, diet, DNA damage, and cell cycle regulation. Certain dietary components such as flavonoids and polyphenols can inhibit cancer progression through p53-mediated mechanisms. In addition, vitamins such as folic acid also play a significant role in chemoprevention.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2021)

Article Multidisciplinary Sciences

Cancer gene mutation frequencies for the US population

Gaurav Mendiratta et al.

Summary: Mutations play a fundamental role in cancer development, generating targetable vulnerabilities; estimates of gene mutation frequencies in the US cancer population were made using genomic and epidemiological data; high-frequency, high-profile cancer driver genes do not dominate cancer genetics as previously suggested.

NATURE COMMUNICATIONS (2021)

Review Oncology

Advances in germline predisposition to acute leukaemias and myeloid neoplasms

Jeffery M. Klco et al.

Summary: This review emphasizes the different genetic pathways impacted by germline mutations leading to the development of familial and sporadic haematological malignancies, with a particular focus on recent advances in acute lymphoblastic leukaemia, acute myeloid leukaemia, and myelodysplastic syndromes.

NATURE REVIEWS CANCER (2021)

Review Microbiology

Human Papillomavirus E6 and E7: The Cervical Cancer Hallmarks and Targets for Therapy

Asmita Pal et al.

FRONTIERS IN MICROBIOLOGY (2020)

Article Public, Environmental & Occupational Health

Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis

Marc Arbyn et al.

LANCET GLOBAL HEALTH (2020)

Article Biochemistry & Molecular Biology

Curcumin stabilizes p53 by interaction with NAD(P)H:quinone oxidoreductase 1 in tumor-derived cell lines

Carlos Cesar Patino-Morales et al.

REDOX BIOLOGY (2020)

Article Engineering, Biomedical

Homotypic Targeting Delivery of siRNA with Artificial Cancer Cells

Lingmin Zhang et al.

ADVANCED HEALTHCARE MATERIALS (2020)

Article Materials Science, Biomaterials

Efficiency of Cytosolic Delivery with Poly(β-amino ester) Nanoparticles is Dependent on the Effective pKa of the Polymer

Denis Routkevitch et al.

ACS BIOMATERIALS SCIENCE & ENGINEERING (2020)

Review Biochemistry & Molecular Biology

P53 in skin cancer: From a master player to a privileged target for prevention and therapy

J. B. Loureiro et al.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2020)

Article Oncology

CRISPR-Cas9 for cancer therapy: Opportunities and challenges

Minjiang Chen et al.

CANCER LETTERS (2019)

Review Biochemistry & Molecular Biology

Roles of E6 and E7 Human Papillomavirus Proteins in Molecular Pathogenesis of Cervical Cancer

Eskandar Taghizadeh et al.

CURRENT PROTEIN & PEPTIDE SCIENCE (2019)

Review Engineering, Biomedical

Poly(β-Amino Esters): Synthesis, Formulations, and Their Biomedical Applications

Yong Liu et al.

ADVANCED HEALTHCARE MATERIALS (2019)

Review Oncology

New therapeutic strategies to treat human cancers expressing mutant p53 proteins

Giovanni Blandino et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)

Review Pharmacology & Pharmacy

Nonviral cancer gene therapy: Delivery cascade and vector nanoproperty integration

Zhuxian Zhou et al.

ADVANCED DRUG DELIVERY REVIEWS (2017)

Review Cell Biology

Beyond editing: repurposing CRISPR-Cas9 for precision genome regulation and interrogation

Antonia A. Dominguez et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2016)

Review Biotechnology & Applied Microbiology

Vectors and strategies for nonviral cancer gene therapy

Jessica Pahle et al.

EXPERT OPINION ON BIOLOGICAL THERAPY (2016)

Article Nanoscience & Nanotechnology

PEG-b-PCL polymeric nano-micelle inhibits vascular angiogenesis by activating p53-dependent apoptosis in zebrafish

Tian Zhou et al.

INTERNATIONAL JOURNAL OF NANOMEDICINE (2016)

Article Biotechnology & Applied Microbiology

CRISPR knockout screening outperforms shRNA and CRISPRi in identifying essential genes

Bastiaan Evers et al.

NATURE BIOTECHNOLOGY (2016)

Article Oncology

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

Jacques Ferlay et al.

INTERNATIONAL JOURNAL OF CANCER (2015)

Article Medicine, Research & Experimental

Restoring expression of wild-type p53 suppresses tumor growth but does not cause tumor regression in mice with a p53 missense mutation

Yongxing Wang et al.

JOURNAL OF CLINICAL INVESTIGATION (2011)

Review Oncology

Human papillomavirus oncoproteins: pathways to transformation

Cary A. Moody et al.

NATURE REVIEWS CANCER (2010)

Article Multidisciplinary Sciences

A polymer library approach to suicide gene therapy for cancer

DG Anderson et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)

Review Microbiology

Pathogenesis of human papillomaviruses in differentiating epithelia

MS Longworth et al.

MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2004)